Piperidinyl and piperazinyl modulators of γ-secretase
申请人:Janssen Pharmaceutica N.V.
公开号:US08252935B2
公开(公告)日:2012-08-28
The present invention relates to compounds of Formula I as shown below, wherein the definitions of Het, R0, R1 R2, R3, R4, R5, R6, R7, R8, and R9 are provided in the specification. Compounds of Formula I are useful for the treatment of diseases associated with γ-secretase activity, including Alzheimer's disease.
[EN] PIPERIDINYL AND PIPERAZINYL MODULATORS OF ?-SECRETASE<br/>[FR] MODULATEUR DE PIPÉRIDINYL ET DE PIPÉRAZINYL DE LA G-SECRÉTASE
申请人:JANSSEN PHARMACEUTICA NV
公开号:WO2009052126A1
公开(公告)日:2009-04-23
The present invention relates to compounds of Formula (I) as shown below, wherein the definitions of Het, R0, R1 R2, R3, R4, R5, R6, R7, R8, and R9 are provided in the specification. Compounds of Formula (I) are useful for the treatment of diseases associated with γ-secretase activity, including Alzheimer´s disease.
PIPERIDINYL AND PIPERAZINYL MODULATORS OF y-SECRETASE
申请人:HO Chih Yung
公开号:US20090105275A1
公开(公告)日:2009-04-23
The present invention relates to compounds of Formula I as shown below, wherein the definitions of Het, R
0
, R
1
R
2
, R
3
, R
4
, R
5
, R
6
, R
7
, R
8
, and R
9
are provided in the specification. Compounds of Formula I are useful for the treatment of diseases associated with γ-secretase activity, including Alzheimer's disease.